NCT00010036
- Conditions
- Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
- Locations
-
- NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States
Clinical trial condition
Glioblastoma
Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.
1,472 public trials
302 recruiting studies
Glioblastoma trial results
NCT00238797
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
- Locations
-
- Research Site Linköping, Sweden
- Research Site Stockholm, Sweden
- Research Site Umeå, Sweden
NCT00069940
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +33 more
- Locations
-
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT01242566
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
- Locations
-
- Pitie salpetriere hospital Paris, France
NCT00720564
- Conditions
- Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +14 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
NCT00118222
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00049296
- Conditions
- AIDS-related Kaposi sarcoma, Adenocarcinoma, Anus Diseases, +155 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00800917
- Conditions
- Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
- Locations
-
- Rigshospitalet Copenhagen, Denmark
NCT00165477
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +9 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Virginia Charlottesville, Virginia, United States
Completed
Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
NCT00503204
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
- Locations
-
- Research Site Boston, Massachusetts, United States
- Research Site Sutton, United Kingdom